Hims & Hers Health, Inc.
Hims & Hers Health Announces $517.5M Convertible Senior Notes Offering
Summary
On May 8, 2025, Hims & Hers Health, Inc. announced its intention to offer $450 million of convertible senior notes due 2030, with an option for an additional $67.5 million, in a private offering to qualified institutional buyers. The proceeds will support global expansion and investment in AI, diagnostics, and personalized treatments. The notes will be senior, unsecured obligations with interest payable semi-annually. Noteholders will have the right to convert their notes under certain conditions, and the Company may redeem the notes under specific circumstances.
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement